Tuesday, January 20, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Energy Fuels Stock Soars on Robust Expansion Study

Robert Sasse by Robert Sasse
January 20, 2026
in Analysis, Commodities, Energy & Oil, Renewable Energy
0
Energy Fuels Stock
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

A newly released feasibility study for Energy Fuels Inc.’s rare earth processing expansion has provided a significant boost, outlining a project with compelling economics and strategic importance for Western supply chains. The market response has been favorable, shifting focus to the company’s execution capabilities for these ambitious plans.

Strategic Supply Chain Ambitions

Mark Chalmers, the Chief Executive Officer, emphasized that Energy Fuels is on the verge of addressing the rare earth processing “bottleneck” in the United States. The company has outlined clear strategic objectives:
* Supplying up to 45% of total U.S. rare earth element demand in the foreseeable future.
* Meeting 100% of domestic demand for critical heavy rare earths, including terbium and dysprosium, by 2030.

The firm cites a strong competitive position underpinned by several factors: production costs ranking among the lowest globally—including when compared to Chinese suppliers—operating margins in the first quartile worldwide, and capital expenditure requirements significantly below those of competitors. This positions Energy Fuels not merely for growth, but for a pivotal role in a value chain historically dominated by China.

Phase 2 Study Reveals Strong Financial Metrics

The bankable feasibility study for the Phase 2 expansion of the White Mesa Mill in Utah presents key financial data highlighting the project’s potential:
* Net Present Value (NPV, 8%): $1.9 billion ($7.96 per share)
* After-Tax Internal Rate of Return (IRR): 33%
* Initial Capital Investment: $410 million (below prior estimates)
* All-In Sustaining Cost: $29.39 per kg of NdPr equivalent
* Average Annual EBITDA: $311 million over the first 15 years

This expansion aims to increase production of neodymium-praseodymium (NdPr) oxide from approximately 1,000 tonnes annually to over 6,000 tonnes. The plan also includes yearly output of roughly 240 tonnes of dysprosium and 66 tonnes of terbium, both heavy rare earth elements crucial for manufacturing high-performance permanent magnets.

Combined Project Value Reaches $3.7 Billion

When incorporating the recently announced Vara-Mada project in Madagascar, which carries its own NPV of $1.8 billion, the total projected value increases substantially.
* Combined NPV: $3.7 billion
* NPV Per Share: $15.26 (based on current share count)
* Aggregate Annual EBITDA: Approximately $765 million per year over the initial 15-year period

This scale explains why management views the expansion as a potential cornerstone for a new Western rare earth supply chain.

Should investors sell immediately? Or is it worth buying Energy Fuels?

Share Performance and Valuation

Energy Fuels’ equity has demonstrated notable strength. On January 16, shares closed at $21.94, marking a daily gain of 4.88%. The performance over extended periods is even more striking:
* Year-to-Date Return: +54.40%
* 1-Year Return: +324.37%
* 52-Week Range: $3.20 to $27.33

The company’s current market capitalization stands at approximately $5.2 billion, with an enterprise value of about $5.11 billion. Given this valuation, investor attention is increasingly focused on the timeline and degree to which the projected values will translate into future operational earnings.

Analyst Sentiment Remains Constructive

HC Wainwright & Co. reaffirmed its “Buy” rating on January 9, maintaining a price target of $26.75. The current average analyst price target is $23.44, with estimates ranging from $13.00 to $32.00. This consensus view remains positive while accounting for varying assessments of execution speed and market risks.

Uranium Division Provides Solid Foundation

Alongside the rare earth business build-out, the uranium division continues to deliver robust results. For the 2025 fiscal year, Energy Fuels exceeded its production and sales targets, manufacturing over one million pounds of finished uranium.

For 2026, the company anticipates deliveries of between 780,000 and 880,000 pounds of U3O8 under long-term contracts. This provides additional cash flow visibility and stability as the major rare earth projects advance.

A significant operational milestone was achieved in December 2025: 99.9% pure dysprosium oxide produced at the White Mesa Mill successfully passed qualification testing by a major South Korean permanent magnet manufacturer. This marks a critical step toward securing industrial offtake agreements in the magnet sector—a central component for realizing the revenue targets outlined in the feasibility study in the coming years.

Ad

Energy Fuels Stock: Buy or Sell?! New Energy Fuels Analysis from January 20 delivers the answer:

The latest Energy Fuels figures speak for themselves: Urgent action needed for Energy Fuels investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 20.

Energy Fuels: Buy or sell? Read more here...

Tags: Energy Fuels
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Intellia Therapeutics Stock
Analysis

Analyst Downgrade Weighs on Intellia Therapeutics Shares

January 20, 2026
Fiserv Stock
Analysis

Fiserv Stock: A Critical Juncture for the Payments Giant

January 20, 2026
The Trade Desk Stock
Analysis

The Trade Desk Stock: A Deep Value Opportunity Emerges from the Selloff

January 20, 2026
Next Post
Hecla Mining Stock

Hecla Mining Shares Surge on Unprecedented Silver Rally

Enovix Stock

Enovix Shares Surge on Battery Validation, Yet Scaling Challenges Loom

The Trade Desk Stock

The Trade Desk Stock: A Deep Value Opportunity Emerges from the Selloff

Recommended

Strategy Stock

Strategy Faces Critical Index Review as MSCI Decision Looms

2 months ago
Anavex Life Sciences Stock

Anavex Faces Critical Regulatory Decision That Could Make or Break the Stock

3 months ago
NRX Pharmaceuticals Stock

NRX Pharma Shares Plunge Following Corporate Update

3 months ago
OHI stock news

State Street Corporations Mixed Results and Strategic Priorities

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Enovix Shares Surge on Battery Validation, Yet Scaling Challenges Loom

Hecla Mining Shares Surge on Unprecedented Silver Rally

Energy Fuels Stock Soars on Robust Expansion Study

DeFi Technologies Stock: A High-Stakes Dilemma for Investors

OMV Shares Navigate Headwinds from Romanian Impairment

Palantir Shares Approach a Critical Juncture

Trending

Intellia Therapeutics Stock
Analysis

Analyst Downgrade Weighs on Intellia Therapeutics Shares

by Felix Baarz
January 20, 2026
0

Intellia Therapeutics' stock is facing renewed pressure following a brief technical rally. While shares closed the previous...

Fiserv Stock

Fiserv Stock: A Critical Juncture for the Payments Giant

January 20, 2026
The Trade Desk Stock

The Trade Desk Stock: A Deep Value Opportunity Emerges from the Selloff

January 20, 2026
Enovix Stock

Enovix Shares Surge on Battery Validation, Yet Scaling Challenges Loom

January 20, 2026
Hecla Mining Stock

Hecla Mining Shares Surge on Unprecedented Silver Rally

January 20, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Analyst Downgrade Weighs on Intellia Therapeutics Shares
  • Fiserv Stock: A Critical Juncture for the Payments Giant
  • The Trade Desk Stock: A Deep Value Opportunity Emerges from the Selloff

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com